Heart Obesity Prevention Education (HOPE)

December 18, 2014 updated by: Tampa General Hospital

Heart Obesity Prevention Education: Retired NFL Players Weight Management Study

Study to collect data on weight management on a male population of retired NFL athletes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Up to ten retired NFL players will receive a comprehensive and monitored weight loss program using a protocol that has been established at the TGH+USF Bariatric Center. A low calorie diet with meal replacements will be used and over the course of the study the participants will be taught to eat low calorie nutritious foods. The sessions will teach proper eating habits, stress control, and skills to maintain a healthy weight.

The length of the study is 6 months. Treatment will last 24 weeks, the participants will attend group sessions (60-90 mins.) on a weekly basis for weeks 1-12 and then every other week for weeks 14-24, for a total of 18 treatments. Treatment will include meal replacement, education on nutrition and proper eating habits as well as behavior modification and skills which is known to be effective.

Participants will be scheduled to come to the Bariatric Center for the first assessment/screening and for the consenting process. TGH+USF Bariatric Center has dedicated clinical space in their suite with private exam rooms, an education classroom, and private testing room.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tampa, Florida, United States, 33606
        • Tampa General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 64 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Males
  • Former NFL players
  • Aged 25-64 (Age range is chosen to keep participants as uniform as possible given the small number of participants. The majority of the players are in this age range and participants need to be able to exercise and be active. Also the NFL in its current form was created in 1970 so there are very few players that are retired from the NFL that are over the age of 65.)
  • BMI >27
  • English- speaking

Exclusion Criteria:

  • Cancer within the last 5 years (except non-melanoma skin cancer)
  • Significant Cardiovascular Disease (recent < 1 year Myocardial Infarction, hospital admission < 1year for Congestive Heart Failure, Active Angina, exercise induced Angina)
  • Malignant arrhythmias (VTACH, AFIB, Aflutter)
  • Renal Disease ( Dialysis or Chronic Renal Insufficiency)
  • Hepatic Disease ( Hepatitis B and C or Liver function test 2.5 times the upper limits of normal, or liver transplant that requires immune odulating/suppressing medications, ammonia lowering medications, or hepatic disease related to diet modification).
  • Psychosis, Severe Anxiety, or Major Depression
  • Significant migraines requiring abortive medication in the last year
  • Significant Endocrine dysfunction ( Cushing's Syndrome )
  • Uncontrolled Hypertension > 160/90
  • Severe arthritis that significantly limits mobility
  • Uncontrolled Hyper/Hypothyroidism
  • Obesity Surgery in the past
  • Weight loss of greater than 10% of the subjects body weight in the last year
  • Recent history (within 1 year ) of Alcohol abuse, illegal Drug abuse
  • Active pulmonary disease that requires daily corticosteroids, an oxygen requirement, or ventilation support for chronic disease management.
  • Participants currently taking or having been taking within the last 3 months the following medication will be excluded.
  • Appetite Suppressants (Phenterimine, Qsymia)
  • Anti-obesity medications (Xenical/Meridia)
  • Corticosteroids or > 1500 micrograms of inhaled steroids daily
  • Raloxifene (Evista) or Temoxifene (HRT medications)
  • Inappropriate use of Testosterone
  • At the discretion of the investigator use of Psychiatric Medication, Sedative/Hypnotics, Benzodiazepines
  • Detailed Disease and Lab Value Exclusion
  • Active rheumatologic, dermatologic disease, or autoimmune/inflammatory condition will be defined as any patient who currently, or has a past medical history of chronic (>2 weeks) immune modulating/suppressing medications.
  • Active renal disease will be defined as any patient who is currently, or has a history requiring potassium phosphate lowering medication, protein restriction diet, or hemo/peritoneal dialysis
  • Screening creatinine >1.5
  • Serious or unstable medical or psychological condition that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study
  • Participants with screening triglycerides above 500 mg.
  • Uncontrolled Dyslipidemia as defined by screening LDL cholesterol >160 mg/dL. Participants on medication treating dyslipidemia for at least 3 months are allowable.
  • Neuropathy that interferes with exercise.
  • Previous weight loss surgery
  • Lab value exclusions are limited to all routine electrolyte values outside the normal range, except glucose.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Ketogenic diet
Weight management on a male population of retired NFL athletes.
Other Names:
  • High protein
  • Low carbohydrate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in body mass index from start of study in 6 month timeframe.
Time Frame: 6 months
Calculate change in weight and BMI
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Gonzalvo, DO, Tampa General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (ACTUAL)

December 1, 2014

Study Completion (ACTUAL)

December 1, 2014

Study Registration Dates

First Submitted

March 13, 2014

First Submitted That Met QC Criteria

March 18, 2014

First Posted (ESTIMATE)

March 20, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

December 19, 2014

Last Update Submitted That Met QC Criteria

December 18, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • TGH0002

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Ketogenic diet

3
Subscribe